JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on July 2, 2008; DOI: 10.1124/jpet.108.140269


0022-3565/08/3271-114-123$20.00
JPET 327:114-123, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.108.140269v1
327/1/114    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kajioka, S.
Right arrow Articles by Brading, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kajioka, S.
Right arrow Articles by Brading, A. F.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Levcromakalim and MgGDP Activate Small Conductance ATP-Sensitive K+ Channels of K+ Channel Pore 6.1/Sulfonylurea Receptor 2A in Pig Detrusor Smooth Muscle Cells: Uncoupling of cAMP Signal Pathways

Shunichi Kajioka, Shinsuke Nakayama, Haruhiko Asano, Narihito Seki, Seiji Naito, and Alison F. Brading

University Department of Pharmacology, Oxford, United Kingdom (S.K., A.F.B.); Department of Cell Physiology, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan (S.Nak.); Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Aichi, Japan (H.A.); and Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan (N.S., S.Nai.)

Pharmacological studies have suggested the existence of ATP-sensitive K+ (KATP) channel as a therapeutic target in urinary bladders; however, electrical properties have not yet been shown. Patch-clamp techniques were applied to investigate the properties of KATP channels in pig detrusor cells. In whole-cell configuration, levcromakalim, a KATP channel opener, induced a long-lasting outward current in a concentration-dependent manner. The current-voltage curve of the levcromakalim-induced membrane current intersected at approximately -80 mV. This current was abolished by glibenclamide. Intracellular application of 0.1 mM GDP significantly enhanced the levcromakalim-induced membrane current, whereas cAMP did not. Furthermore, neurotransmitters related to cAMP signaling, such as calcitonin gene-related peptide, vasointestinal peptide, adenosine, and somatostatin, had little effect on the membrane current. In cell-attached configuration, levcromakalim activated K+ channels with a unitary conductance of ~12 pS. When the patch configuration was changed to inside-out mode, the K+ channel activity ran down. Subsequent application of 1 mM GDP reactivated the channels. The openings of the ~12 pS K+ channels in the presence of 1 mM GDP was suppressed by ATP and glibenclamide. In reverse transcription-polymerase chain reaction, K+ channel pore 6.1 and sulfonylurea receptor (SUR)2A were predominant in pig detrusor cells. The 12 pS K+ channel activated by levcromakalim in pig detrusor smooth muscle cells is a KATP channel. The predominant expression of SUR2A can account for the lack of effect of neurotransmitters related to cAMP.


Received April 22, 2008; accepted July 1, 2008.

Address correspondence to: Dr. Shinsuke Nakayama, Department of Cell Physiology, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan. E-mail: h44673a{at}nucc.cc.nagoya-u.ac.jp







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.